Mirae Asset Global Investments Co., Ltd. Editas Medicine, Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

$20 Billion
Q2 2024

A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,455 shares of EDIT stock, worth $9,697. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,455

Previous 314,774 99.22%

Holding current value

$9,697

Previous $2.34 Million 99.53%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	SELL	$4.67 - $7.28 $1.46 Million - $2.27 Million	-312,319 Reduced 99.22%	2,455 $11,000
Q1 2024 May 01, 2024	BUY	$7.03 - $11.07 $821,125 - $1.29 Million	116,803 Added 59.0%	314,774 $2.34 Million
Q4 2023 Jan 24, 2024	SELL	$6.25 - $11.11 $1.11 Million - $1.97 Million	-177,556 Reduced 47.28%	197,971 $2.01 Million
Q3 2023 Oct 26, 2023	BUY	$6.92 - $9.31 $181,511 - $244,201	26,230 Added 7.51%	375,527 $2.93 Million
Q2 2023 Aug 10, 2023	BUY	$6.36 - $11.47 $199,831 - $360,387	31,420 Added 9.88%	349,297 $2.87 Million
Q1 2023 May 04, 2023	BUY	$7.03 - $11.53 $198,773 - $326,010	28,275 Added 9.76%	317,877 $2.3 Million
Q4 2022 Feb 09, 2023	SELL	$8.32 - $13.21 $525,299 - $834,039	-63,137 Reduced 17.9%	289,602 $2.57 Million
Q3 2022 Nov 10, 2022	BUY	$12.16 - $19.42 $560,332 - $894,873	46,080 Added 15.03%	352,739 $4.32 Million
Q2 2022 Jul 26, 2022	BUY	$9.99 - $21.35 $893,685 - $1.91 Million	89,458 Added 41.19%	306,659 $3.63 Million
Q1 2022 May 10, 2022	SELL	$14.08 - $27.63 $616,844 - $1.21 Million	-43,810 Reduced 16.78%	217,201 $4.13 Million
Q4 2021 Feb 08, 2022	BUY	$26.55 - $40.57 $1.49 Million - $2.27 Million	55,940 Added 27.28%	261,011 $6.93 Million
Q3 2021 Nov 15, 2021	BUY	$39.27 - $72.94 $1.51 Million - $2.8 Million	38,454 Added 23.08%	205,071 $8.42 Million
Q2 2021 Aug 11, 2021	BUY	$31.29 - $56.64 $877,402 - $1.59 Million	28,041 Added 20.24%	166,617 $9.44 Million
Q1 2021 May 13, 2021	BUY	$39.71 - $90.58 $2.49 Million - $5.68 Million	62,711 Added 82.66%	138,576 $5.82 Million
Q4 2020 Feb 10, 2021	BUY	$27.07 - $84.35 $681,433 - $2.12 Million	25,173 Added 49.66%	75,865 $5.32 Million
Q3 2020 Nov 12, 2020	BUY	$28.06 - $37.16 $446,743 - $591,624	15,921 Added 45.79%	50,692 $1.42 Million
Q2 2020 Aug 11, 2020	BUY	$18.5 - $34.34 $276,131 - $512,558	14,926 Added 75.21%	34,771 $1.03 Million
Q1 2020 May 12, 2020	BUY	$14.88 - $32.78 $32,230 - $71,001	2,166 Added 12.25%	19,845 $393,000
Q4 2019 Feb 12, 2020	BUY	$19.49 - $32.63 $47,146 - $78,931	2,419 Added 15.85%	17,679 $524,000
Q3 2019 Nov 12, 2019	BUY	$22.49 - $26.81 $343,197 - $409,120	15,260 New	15,260 $347,000

Others Institutions Holding EDIT

# of Institutions

252

Shares Held

58.7M

Call Options Held

494K

Put Options Held

417K

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $272M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Account

Mirae Asset Global Investments Co., Ltd. Editas Medicine, Inc. Transaction History